Phyllis Gotlib Sells 3,573 Shares of American Well (NYSE:AMWL) Stock

American Well Corporation (NYSE:AMWL) insider Phyllis Gotlib sold 3,573 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $9.74, for a total transaction of $34,801.02. Following the sale, the insider owned 159,431 shares of the company’s stock, valued at approximately $1,552,857.94. The trade was a 2.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Phyllis Gotlib also recently made the following trade(s):

• On Wednesday, April 1st, Phyllis Gotlib sold 3,706 shares of American Well stock. The stock was sold at an average price of $5.30, for a total transaction of $19,641.80.

American Well Price Performance

Shares of NYSE AMWL opened at $8.87 on Friday. The company has a 50 day simple moving average of $6.86 and a 200-day simple moving average of $5.54. The company has a market capitalization of $146.78 million, a P/E ratio of -1.64 and a beta of 1.69. American Well Corporation has a 1 year low of $3.71 and a 1 year high of $9.96.

American Well (NYSE:AMWL) last announced its quarterly earnings results on Tuesday, May 5th. The company reported ($0.66) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.77) by $0.11. The business had revenue of $54.88 million during the quarter, compared to the consensus estimate of $51.54 million. American Well had a negative net margin of 37.02% and a negative return on equity of 32.11%. As a group, research analysts expect that American Well Corporation will post -2.68 EPS for the current year.

Hedge Funds Weigh In On American Well

Hedge funds have recently made changes to their positions in the stock. JPMorgan Chase & Co. boosted its position in American Well by 16.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company’s stock valued at $131,000 after buying an additional 2,081 shares during the period. Geode Capital Management LLC boosted its position in American Well by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 152,742 shares of the company’s stock valued at $750,000 after buying an additional 3,450 shares during the period. State Street Corp boosted its position in American Well by 7.8% in the 4th quarter. State Street Corp now owns 52,299 shares of the company’s stock valued at $257,000 after buying an additional 3,800 shares during the period. Headlands Technologies LLC purchased a new position in American Well in the 2nd quarter valued at approximately $39,000. Finally, Two Sigma Investments LP boosted its position in American Well by 22.6% in the 3rd quarter. Two Sigma Investments LP now owns 46,329 shares of the company’s stock valued at $285,000 after buying an additional 8,553 shares during the period. Hedge funds and other institutional investors own 56.05% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on AMWL shares. Morgan Stanley raised their price target on shares of American Well from $6.00 to $6.50 and gave the stock an “equal weight” rating in a report on Wednesday, May 6th. Stifel Nicolaus cut their price target on shares of American Well from $6.00 to $5.00 and set a “hold” rating for the company in a report on Friday, February 13th. TD Cowen raised their price target on shares of American Well from $5.00 to $8.00 and gave the stock a “hold” rating in a report on Wednesday, May 6th. Finally, Wall Street Zen upgraded shares of American Well from a “sell” rating to a “hold” rating in a report on Sunday, March 22nd. One research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $7.13.

American Well Company Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.